• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥地利西部的甲型肝炎——主动免疫引入前的流行病学情况。

Hepatitis A in Western Austria--the epidemiological situation before the introduction of active immunisation.

作者信息

Prodinger W M, Larcher C, Sölder B M, Geissler D, Dierich M P

机构信息

Institut für Hygiene, Universität Innsbruck, Austria.

出版信息

Infection. 1994 Jan-Feb;22(1):53-5. doi: 10.1007/BF01780769.

DOI:10.1007/BF01780769
PMID:8181844
Abstract

Several European countries report a decreasing prevalence of antibodies to hepatitis A virus (anti-HAV). This trend is most pronounced in the youngest age groups. In 1979, however, 58% of young Austrians aged 20 to 30 years were shown to possess anti-HAV. Here we describe the current epidemiological situation in western Austria. Prevalence of anti-HAV has decreased to 7% in those 18 to 30 years old. This percentage rises to 20% (31 to 40 years of age) and 57% (41 to 50 years of age) and is highest in those older than 50 years (87%). Of 180 cases of clinical hepatitis A occurring from 1985 to 1992 45% were imported by travel to HAV-endemic areas. Seventy-one percent of the cases in children (59/83) occurred in foreign workers' families and were also predominantly acquired abroad. A change in prevention policy should be considered in this respect, as vaccination is available now.

摘要

几个欧洲国家报告甲型肝炎病毒抗体(抗-HAV)的流行率在下降。这一趋势在最年轻的年龄组中最为明显。然而,1979年,20至30岁的奥地利年轻人中有58%被证明拥有抗-HAV。在此,我们描述奥地利西部目前的流行病学情况。18至30岁人群中抗-HAV的流行率已降至7%。这一比例在31至40岁人群中升至20%,在41至50岁人群中升至57%,在50岁以上人群中最高(87%)。在1985年至1992年发生的180例临床甲型肝炎病例中,45%是因前往甲型肝炎流行地区旅行而输入的。儿童病例(59/83)中有71%发生在外国工人家庭,也主要是在国外感染的。鉴于现在有疫苗可用,在这方面应考虑改变预防政策。

相似文献

1
Hepatitis A in Western Austria--the epidemiological situation before the introduction of active immunisation.奥地利西部的甲型肝炎——主动免疫引入前的流行病学情况。
Infection. 1994 Jan-Feb;22(1):53-5. doi: 10.1007/BF01780769.
2
Hepatitis A infection: a seroepidemiological study in young adults in North-East Italy.甲型肝炎感染:意大利东北部年轻人的血清流行病学研究
Eur J Epidemiol. 1997 Dec;13(8):875-8. doi: 10.1023/a:1007450416869.
3
Hepatitis A antibody titres after infection and immunization: implications for passive and active immunization.感染和免疫后的甲型肝炎抗体滴度:对被动免疫和主动免疫的影响
J Med Virol. 1993 May;40(1):22-7. doi: 10.1002/jmv.1890400106.
4
Exposure of Indian children to hepatitis A virus & vaccination age.
Indian J Med Res. 1999 Jan;109:11-5.
5
Testing for antibody to hepatitis A to decrease the cost of hepatitis A prophylaxis with immune globulin or hepatitis A vaccines.检测甲型肝炎抗体以降低使用免疫球蛋白或甲型肝炎疫苗进行甲型肝炎预防的成本。
Arch Intern Med. 1994 Mar 28;154(6):663-8.
6
The prevalence of hepatitis A antibodies among Israeli travellers and the economic feasibility of screening before vaccination.以色列旅行者中甲型肝炎抗体的流行情况以及疫苗接种前筛查的经济可行性。
Int J Epidemiol. 1998 Feb;27(1):118-20. doi: 10.1093/ije/27.1.118.
7
[Prevalence of hepatitis A antibody among population covered by different hepatitis A immunization strategies in Shandong Province, 2015, China].[2015年中国山东省不同甲型肝炎免疫策略覆盖人群中甲肝抗体流行情况]
Zhonghua Yu Fang Yi Xue Za Zhi. 2017 Jun 6;51(6):480-483. doi: 10.3760/cma.j.issn.0253-9624.2017.06.005.
8
The shift in prevalence of hepatitis A immunity in Flanders, Belgium.比利时弗拉芒地区甲型肝炎免疫流行情况的变化。
Acta Gastroenterol Belg. 1998 Jan-Mar;61(1):4-7.
9
The impact of universal live attenuated hepatitis A vaccines in Henan, China, 2005-2018.2005-2018 年中国河南甲肝减毒活疫苗广泛使用的影响。
Int J Infect Dis. 2020 Apr;93:163-167. doi: 10.1016/j.ijid.2020.02.001. Epub 2020 Feb 8.
10
Declining prevalence of hepatitis A virus antibodies among children from low socioeconomic groups reinforces the need for the implementation of hepatitis A vaccination in Brazil.来自社会经济地位较低群体的儿童中甲型肝炎病毒抗体流行率下降,这强化了在巴西实施甲型肝炎疫苗接种的必要性。
Mem Inst Oswaldo Cruz. 2012 Aug;107(5):652-8. doi: 10.1590/s0074-02762012000500012.

引用本文的文献

1
Hepatitis A incidence and hospital-based seroprevalence in Italy: a nation-wide study.意大利甲型肝炎发病率及基于医院的血清学患病率:一项全国性研究。
Eur J Epidemiol. 2008;23(1):45-53. doi: 10.1007/s10654-007-9198-y. Epub 2007 Nov 3.
2
Seroprevalence of hepatitis A infection in a low endemicity country: a systematic review.低流行率国家甲型肝炎感染的血清流行率:一项系统综述
BMC Infect Dis. 2005 Jul 7;5:56. doi: 10.1186/1471-2334-5-56.
3
Prevalence of markers for hepatitis A, B and C in the German population. Results of the German National Health Interview and Examination Survey 1998.

本文引用的文献

1
Vaccination of adults against travel-related infectious diseases, and new developments in vaccines.成人针对旅行相关传染病的疫苗接种及疫苗的新进展。
Infection. 1993 Jan-Feb;21(1):1-17. doi: 10.1007/BF01739302.
2
Antibody to hepatitis A virus in plasma of Danish blood donors and in immune serum globulin produced in Denmark.
Scand J Infect Dis. 1980;12(2):81-3. doi: 10.3109/inf.1980.12.issue-2.01.
3
Hepatitis A in young Norwegian drug addicts and prison inmates.
Infection. 1988 Mar-Apr;16(2):91-4. doi: 10.1007/BF01644310.
4
德国人群中甲型、乙型和丙型肝炎标志物的流行情况。1998年德国国民健康访谈与检查调查结果。
Eur J Epidemiol. 2001;17(5):429-35. doi: 10.1023/a:1013792013184.
4
Prevalence of hepatitis A, B and C in the Flemish population.弗拉芒人群中甲型、乙型和丙型肝炎的患病率。
Eur J Epidemiol. 1997 Apr;13(3):275-80. doi: 10.1023/a:1007393405966.
5
Prevalence of hepatitis C virus infection in Hashimoto's thyroiditis.桥本甲状腺炎中丙型肝炎病毒感染的患病率。
BMJ. 1996 Mar 9;312(7031):640-1. doi: 10.1136/bmj.312.7031.640b.
Immunogenicity of a killed hepatitis A vaccine in seronegative volunteers.灭活甲型肝炎疫苗在血清阴性志愿者中的免疫原性。
Lancet. 1989 May 13;1(8646):1039-41. doi: 10.1016/s0140-6736(89)92443-4.
5
Changing epidemiology and clinical aspects of hepatitis A.甲型肝炎流行病学与临床特征的变化
Br Med Bull. 1990 Apr;46(2):303-18. doi: 10.1093/oxfordjournals.bmb.a072400.
6
Hepatitis A virus antibody in East Anglian blood donors.东安格利亚地区献血者中的甲型肝炎病毒抗体
Lancet. 1990 Nov 24;336(8726):1330. doi: 10.1016/0140-6736(90)93024-j.
7
Safety and immunogenicity of an inactivated hepatitis A candidate vaccine in healthy adult volunteers.
Vaccine. 1990 Dec;8(6):581-4. doi: 10.1016/0264-410x(90)90013-c.
8
Hepatitis A virus antibodies in Belgium: relationship between prevalence and age.比利时甲型肝炎病毒抗体:流行率与年龄之间的关系。
Infection. 1990 Nov-Dec;18(6):364-6. doi: 10.1007/BF01646408.
9
A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children.健康儿童中福尔马林灭活甲型肝炎疫苗的对照试验。
N Engl J Med. 1992 Aug 13;327(7):453-7. doi: 10.1056/NEJM199208133270702.
10
Antibody against hepatitis A in seven European countries. I. Comparison of prevalence data in different age groups.七个欧洲国家甲型肝炎抗体情况。I. 不同年龄组患病率数据比较
Am J Epidemiol. 1979 Jul;110(1):63-9. doi: 10.1093/oxfordjournals.aje.a112788.